{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:21:04Z","timestamp":1785817264206,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.radonc.2026.111470","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:13:05Z","timestamp":1772583185000},"page":"111470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor organoids modeling reveals timed responses and interplay of radiotherapy and chemotherapy in pancreatic cancer"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-5626","authenticated-orcid":false,"given":"Chayu","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8730-5435","authenticated-orcid":false,"given":"Zachery","family":"Keepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hem D.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2384-5676","authenticated-orcid":false,"given":"Lei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111470_b0005","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.gendis.2023.02.052","article-title":"Cancer organoids: a platform in basic and translational research","volume":"11","author":"Ma","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.radonc.2026.111470_b0010","first-page":"319","article-title":"Tumor organoids for cancer research and personalized medicine","volume":"19","author":"Yang","year":"2022","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.radonc.2026.111470_b0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43556-023-00165-9","article-title":"Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine","volume":"5","author":"Qu","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.radonc.2026.111470_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-022-00356-6","article-title":"Clinical translation of patient-derived tumor organoids-bottlenecks and strategies","volume":"10","author":"Foo","year":"2022","journal-title":"Biomarker Res"},{"key":"10.1016\/j.radonc.2026.111470_b0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-021-00168-1","article-title":"Patient-derived organoids as a predictive biomarker for treatment response in cancer patients","volume":"5","author":"Wensink","year":"2021","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0030","article-title":"Patient-derived tumor organoids: new progress and opportunities to facilitate precision cancer immunotherapy","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0035","doi-asserted-by":"crossref","unstructured":"Pasch CA, Favreau PF, Yueh AE, et al. Patient-derived cancer organoid cultures to predict sensitivity to chemotherapy and radiation. Clin. Cancer Res. 25(17), 2019.","DOI":"10.1158\/1078-0432.CCR-18-3590"},{"key":"10.1016\/j.radonc.2026.111470_b0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0045","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tips.2022.03.014","article-title":"3D cell cultures toward quantitative high-throughput drug screening","volume":"43","author":"Wang","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.radonc.2026.111470_b0050","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2026.111470_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1072774","article-title":"Pancreatic cancer derived 3D organoids as a clinical tool to evaluate the treatment response","volume":"12","author":"Shukla","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41420-024-01871-1","article-title":"SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoids","volume":"10","author":"Roy","year":"2024","journal-title":"Cell Death Disc."},{"key":"10.1016\/j.radonc.2026.111470_b0065","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2026.111470_b0070","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.radonc.2026.111470_b0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111470_b0080","first-page":"17","article-title":"Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Clin. Translat. Rep."},{"key":"10.1016\/j.radonc.2026.111470_b0085","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0703","article-title":"Towards personalized computational oncology: from spatial models of tumor spheroids, to organoids, to tissues","volume":"15","author":"Karolak","year":"2018","journal-title":"J R Soc Interface"},{"key":"10.1016\/j.radonc.2026.111470_b0090","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fgene.2019.00873","article-title":"Mathematical models of organoid cultures","volume":"10","author":"Montes-Olivas","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.radonc.2026.111470_b0095","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/sym14040704","article-title":"Mathematical modeling and analysis of tumor chemotherapy","volume":"14","author":"Song","year":"2022","journal-title":"Symmetry"},{"key":"10.1016\/j.radonc.2026.111470_b0100","doi-asserted-by":"crossref","first-page":"17674","DOI":"10.1038\/s41598-019-54117-x","article-title":"A cellular automaton model for spheroid response to radiation and hyperthermia treatments","volume":"9","author":"Bruningk","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111470_b0105","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.3390\/cancers15235645","article-title":"Efficient radial-shell model for 3D tumor spheroid dynamics with radiotherapy","volume":"15","author":"Franke","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2026.111470_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012256","article-title":"Understanding patient-derived tumor organoid growth through an integrated imaging and mathematical modeling framework","volume":"20","author":"Gunnarsson","year":"2024","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.radonc.2026.111470_b0115","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1038\/s41467-023-39122-z","article-title":"Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects","volume":"14","author":"Gross","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2026.111470_b0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcell.2020.00041","article-title":"Molecular mechanisms of radiation-induced cancer cell death: a primer","volume":"8","author":"Sia","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.radonc.2026.111470_b0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12943-025-02374-y","article-title":"Establishing 3D organoid models from patient-derived conditionally reprogrammed cells to bridge preclinical and clinical insights in pancreatic cancer","volume":"24","author":"Kim","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.radonc.2026.111470_b0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/biomedicines8120609","article-title":"Combinatorial effect of magnetic field and radiotherapy in PDAC organoids: a pilot study","volume":"8","author":"Nicosia","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.radonc.2026.111470_b0135","article-title":"Radiation response assessment of organoids derived from patients with pancreatic cancer","volume":"48","author":"van Goor","year":"2024","journal-title":"Clin. Translat. Radiat. Oncol."},{"key":"10.1016\/j.radonc.2026.111470_b0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1116\/1.3625258","article-title":"Direct assessment of living cell mechanical responses during deformation inside microchannel restrictions","volume":"6","author":"Walter","year":"2011","journal-title":"Biointerphases"},{"key":"10.1016\/j.radonc.2026.111470_b0145","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111470_b0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41698-023-00480-y","article-title":"Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer","volume":"7","author":"Le Compte","year":"2023","journal-title":"npj Precis. Onc"},{"key":"10.1016\/j.radonc.2026.111470_b0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12976-016-0032-7","article-title":"A mathematical model of tumor growth and its response to single irradiation","volume":"13","author":"Watanabe","year":"2016","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.radonc.2026.111470_b0160","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/adec38","article-title":"A predictive model studying the impact of timing and order for the combination-regime of spatially fractionated radiation therapy and stereotactic body radiation therapy","volume":"70","author":"Yang","year":"2025","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2026.111470_b0165","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.ijrobp.2018.06.250","article-title":"Estimation of the alpha-beta ratio for chemoradiation of locally advanced pancreatic cancer","volume":"102","author":"Prior","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111470_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13014-022-02184-2","article-title":"Radiation-induced senescence: therapeutic opportunities","volume":"18","author":"Kim","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0175","doi-asserted-by":"crossref","unstructured":"Daguenet E, Louati S, Wozny, AS. Et al. Radiation-induced bystander and abscopal effects: important lessons from preclinical models. Br J Cancer 123, 339-348 (2020).","DOI":"10.1038\/s41416-020-0942-3"},{"key":"10.1016\/j.radonc.2026.111470_b0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0360-3016(00)01471-1","article-title":"Low-dose hypersensitivity: current status and possible mechanisms","volume":"49","author":"Joiner","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111470_b0185","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/srep13249","article-title":"Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells","volume":"5","author":"Yoshino","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111470_b0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0093-7754(03)00268-9","article-title":"Chemotherapy and irradiation interaction","volume":"30","author":"Choy","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21873\/anticanres.14746","article-title":"Chemoradiotherapy in cancer treatment: rationale and clinical applications","volume":"41","author":"Rallis","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2026.111470_b0200","article-title":"Advances of patient-derived organoids in personalized radiotherapy","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0205","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/bjc.2011.276","article-title":"Objective assessment of tumor response to therapy based on tumor growth kinetics","volume":"105","author":"Mehrara","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2026.111470_b0210","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/s12276-024-01272-5","article-title":"Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology","volume":"56","author":"Thorel","year":"2024","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.radonc.2026.111470_b0215","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.3390\/jcm13206251","article-title":"Breast cancer adjuvant radiotherapy and chemotherapy sequencing: sequential, concomitant, or what else? a comprehensive review of the adjuvant combinations journey","volume":"13","author":"Lazzari","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2026.111470_b0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fonc.2016.00165","article-title":"Challenges of using high-dose fractionation radiotherapy in combination therapy","volume":"6","author":"Yang","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111470_b0225","doi-asserted-by":"crossref","unstructured":"Keepers ZL, Roy S, William R, et al. Patient-derived pancreatic tumor organoids as a tool to evaluate cancer stem cell populations and their role in therapeutic resistance. Cancer Res 2024;84(17 Suppl_2):Abstract nr B086.","DOI":"10.1158\/1538-7445.PANCREATIC24-B086"},{"key":"10.1016\/j.radonc.2026.111470_b0230","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/812398","article-title":"A review of ERCC1 gene in bladder cancer: implications for carcinogenesis and resistance to chemoradiotherapy","volume":"2012","author":"Kawashima","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.radonc.2026.111470_b0235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111470_b0240","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111470_b0245","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.18632\/oncotarget.13857","article-title":"Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment","volume":"8","author":"Daster","year":"2017","journal-title":"Oncotarget"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:13:44Z","timestamp":1781122424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402600109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"alternative-id":["S016781402600109X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111470","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor organoids modeling reveals timed responses and interplay of radiotherapy and chemotherapy in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111470"}}